GFAP and neurodegenerative disease: These consisted of markers of astrocytic and microglial activation (GFAP, vimentin, galectin-1, and clusterin) and indicators of neurodegenerative disease (ApoE and serpinA3N) that each demonstrated significant prion effects and PAM effects from the MS proteomic analysis (Fig. 5A).